Next Article in Journal
Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma
Next Article in Special Issue
CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival
Previous Article in Journal
Minimizing MRONJ after Tooth Extraction in Cancer Patients Receiving Bone-Modifying Agents
Previous Article in Special Issue
The Potential Role of Proinflammatory Cytokines and Complement Components in the Development of Drug-Induced Neuropathy in Patients with Multiple Myeloma
 
 
Review

Article Versions Notes

J. Clin. Med. 2022, 11(7), 1809; https://doi.org/10.3390/jcm11071809
Action Date Notes Link
article xml file uploaded 25 March 2022 05:15 CET Original file -
article xml uploaded. 25 March 2022 05:15 CET Update https://www.mdpi.com/2077-0383/11/7/1809/xml
article pdf uploaded. 25 March 2022 05:15 CET Version of Record https://www.mdpi.com/2077-0383/11/7/1809/pdf
article html file updated 25 March 2022 05:17 CET Original file -
article html file updated 1 August 2022 07:30 CEST Update https://www.mdpi.com/2077-0383/11/7/1809/html
Back to TopTop